KBR-1001

N/A

Report date: 2025/06/11 10:43:10
NME

Base Information

Drug NameKBR-1001
Drug Alias NameRoR-gamma t antagonist (Krish Biotech)KBRPL-1001KBR-1001
ClassificationSmall molecules
Mechanisms of ActionNuclear receptor ROR-gamma antagonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPiramal Enterprises Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A